NASDAQ · Financial Statements

Atrium Therapeutics, Inc. (RNA) Financial Statements

$8.20 NASDAQ: RNA Market Cap $140.27M

Atrium Therapeutics, Inc. most recently reported annual revenue of $19.0M, a net loss of $77.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Income Statement — 1 Years (USD millions)

Metric2025
Revenue$19.0M
Operating Expenses$95.0M
Operating Profit$-77.0M
Operating Margin-412.6%
Other Income$0
Interest$0
Depreciation$0
Profit Before Tax$-77.0M
Tax$180,000
Net Profit$-77.0M
EPS$-4.48
Dividend Payout0.0%

Quarterly Results — Last 4 Quarters (USD millions)

MetricSep '25Dec '25Mar '26Jun '26
Revenue$0$1.0M$20.0M$3.0M
Operating Expenses$8.0M$49.0M$37.0M$26.0M
Operating Profit$-8.0M$-48.0M$-17.0M$-23.0M
Operating Margin0.0%-5592.0%-88.0%-752.9%
Interest$0$0$0$0
Profit Before Tax$-8.0M$-48.0M$-17.0M$-20.0M
Tax$2.1M$-70,000$0$0
Net Profit$-8.0M$-48.0M$-17.0M$-20.0M
EPS$0.00$-1.70$-0.97$-1.18

Balance Sheet — 1 Years (USD millions)

Metric2025
Total Assets$278.0M
Current Assets$273.0M
Cash$270.0M
Inventory$0
Receivables$0
Fixed Assets$6.0M
Capital Work in Progress$0
Investments$0
Other Assets$0
Total Liabilities$71.0M
Current Liabilities$42.0M
Borrowings$4.0M
Other Liabilities$67.0M
Equity$0
Reserves$207.0M

Cash Flow Statement — 1 Years (USD millions)

Metric2025
Operating Cash Flow$-41.0M
Investing Cash Flow$-3.0M
Financing Cash Flow$43.0M
Net Cash Flow$0
Free Cash Flow$-43.0M

Atrium Therapeutics, Inc. (RNA) financials — frequently asked questions

What is Atrium Therapeutics, Inc.'s annual revenue?

Atrium Therapeutics, Inc. (RNA) reported annual revenue of $19.0M in its most recent fiscal year.

What is Atrium Therapeutics, Inc.'s net profit?

Atrium Therapeutics, Inc. (RNA) reported a net loss of $77.0M in its most recent fiscal year.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
RNA Overview RNA Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.